PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786412
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786412
Global Diabetes Care Devices Market to Reach US$86.9 Billion by 2030
The global market for Diabetes Care Devices estimated at US$48.2 Billion in the year 2024, is expected to reach US$86.9 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$51.1 Billion by the end of the analysis period. Growth in the Insulin Delivery Devices segment is estimated at 7.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$13.1 Billion While China is Forecast to Grow at 14.4% CAGR
The Diabetes Care Devices market in the U.S. is estimated at US$13.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$18.2 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.
The diabetes care devices market is undergoing a revolutionary shift, driven by technological innovations that are improving disease monitoring, management, and treatment adherence. The development of continuous glucose monitoring (CGM) systems has been a game-changer, providing real-time insights into blood sugar fluctuations and reducing dependence on traditional fingerstick testing. Additionally, insulin delivery systems, such as smart insulin pens and closed-loop insulin pumps, are making diabetes management more precise and convenient. The rise of digital health integration has further enhanced remote monitoring capabilities, allowing healthcare providers to personalize treatment plans based on real-time data. Moreover, the increasing prevalence of diabetes worldwide, particularly in developing regions, has spurred the demand for affordable and user-friendly diabetes care devices. Companies are now focusing on miniaturization and non-invasive technologies to make devices more accessible and less cumbersome for patients.
The latest wave of innovations in diabetes care devices is centered around automation, AI-driven analytics, and non-invasive monitoring. Artificial pancreas systems, which automatically adjust insulin delivery based on continuous glucose readings, are revolutionizing diabetes control. Wearable and implantable sensors are emerging as promising alternatives to traditional CGMs, offering improved accuracy and longer wear durations. Smart patches with microneedle technology are also gaining traction for pain-free glucose monitoring. Another key development is the integration of AI-driven predictive analytics, which helps detect patterns and anticipate glucose fluctuations before they occur. Additionally, advances in biosensor technology are paving the way for glucose monitoring through sweat and tears, eliminating the need for invasive blood sampling. With these innovations, diabetes management is becoming more efficient and less intrusive for patients.
The integration of digital health solutions, including mobile apps, cloud-based platforms, and telemedicine, is revolutionizing diabetes management. Smartphone-connected glucose monitors allow users to track their readings, receive real-time alerts, and share data with healthcare providers seamlessly. The proliferation of AI-driven diabetes coaching apps is also empowering patients with personalized dietary and lifestyle recommendations. The rise of remote patient monitoring programs has further strengthened chronic disease management, especially in underserved regions where access to endocrinologists is limited. Insurance companies and employers are also increasingly adopting diabetes management programs that integrate digital tools to promote proactive care. These developments are significantly enhancing patient engagement and long-term disease control.
The growth in the diabetes care devices market is driven by several factors, including rising diabetes prevalence, growing demand for minimally invasive monitoring solutions, and increasing adoption of digital health technologies. The expansion of artificial pancreas systems and advanced insulin delivery devices is significantly improving patient outcomes, fueling market growth. Additionally, continuous innovations in biosensor technology are making glucose monitoring more accurate and user-friendly. The increasing penetration of AI in diabetes management is also playing a pivotal role in predicting and preventing complications. Moreover, government initiatives to promote diabetes awareness and improve access to care are further accelerating market expansion. The rapid uptake of wearable health technologies and telehealth solutions is enhancing disease monitoring and treatment adherence, propelling further growth. With the ongoing technological advancements and growing patient-centric approaches, the diabetes care devices market is expected to witness sustained expansion in the coming years.
SCOPE OF STUDY:
The report analyzes the Diabetes Care Devices market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices); End-Use (Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.